Glioblastoma (GBM) is a rapidly spreading and aggressive brain tumor. Current treatment for this cancer is limited, however, a recent animal study has shown that a drug made from the natural compound indirubin—derived from traditional Chinese medicine (TCM)—can improve the survival rate of mice with the disease, thus offering a potential new avenue for its treatment in humans.
GBM is the most prevalent and aggressive form of brain cancer, most commonly occurring in those over 64 years of age. Symptoms of GBM encompass gradually intensifying headaches, bouts of nausea and vomiting, impaired or dual vision, and episodes of seizures.
